Cell membrane-engineered nanoparticles: A bionic platform for targeted cancer therapy

Area of Science:

• Nanomedicine
• Biomaterials Science
• Oncology

Background:

• Cancer drug delivery faces challenges with conventional and nanomedicine approaches.
• Current nanocarriers exhibit off-target effects and limited barrier penetration.
• Biomimicking nanoparticles, especially cell membrane-coated ones, offer improved circulation and tumor interaction.

Purpose of the Study:

• To review advancements and limitations of biomimicking nanocarriers for cancer treatment.
• To focus on cell membrane-coated nanocarriers, their types, fabrication, and applications.
• To provide a roadmap for future research and clinical implementation.

Main Methods:

• Review of recent literature on biomimicking nanocarriers for cancer therapy.
• Analysis of cell membrane-coating strategies and their impact on nanoparticle function.
• Discussion of fabrication methods, sources, challenges, and applications.

Main Results:

• Cell membrane-coated nanoparticles demonstrate enhanced circulation half-life and immune evasion.
• These biomimicking systems show potential for improved tumor microenvironment interaction.
• Key challenges include manufacturing scalability, immunogenicity, and regulatory hurdles.

Conclusions:

• Biomimicking nanocarriers represent a promising strategy for targeted cancer drug delivery.
• Overcoming manufacturing and regulatory challenges is crucial for clinical translation.
• Further research is needed to optimize these systems for effective cancer treatment.